Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3409957rdf:typepubmed:Citationlld:pubmed
pubmed-article:3409957lifeskim:mentionsumls-concept:C0006675lld:lifeskim
pubmed-article:3409957lifeskim:mentionsumls-concept:C1280551lld:lifeskim
pubmed-article:3409957lifeskim:mentionsumls-concept:C0205042lld:lifeskim
pubmed-article:3409957lifeskim:mentionsumls-concept:C0001443lld:lifeskim
pubmed-article:3409957lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:3409957lifeskim:mentionsumls-concept:C1550548lld:lifeskim
pubmed-article:3409957lifeskim:mentionsumls-concept:C1555714lld:lifeskim
pubmed-article:3409957lifeskim:mentionsumls-concept:C1705654lld:lifeskim
pubmed-article:3409957lifeskim:mentionsumls-concept:C1140999lld:lifeskim
pubmed-article:3409957pubmed:issue3lld:pubmed
pubmed-article:3409957pubmed:dateCreated1988-10-5lld:pubmed
pubmed-article:3409957pubmed:abstractText3,4-Diaminopyridine, a potassium (K+) channel blocker, was used to induce phasic contractions in an isolated K+-contracted dog left anterior descending coronary artery ring preparation. The effects of adenosine, N6-L-phenyl-isopropyl-adenosine (L-PIA) and 5'-N-ethylcarboxamide-adenosine (NECA) were compared with those of calcium (Ca2+) entry blockers (nifedipine, verapamil, diltiazem) on the maximum developed force, minimum developed force and contraction frequency in this model. Adenosine, L-PIA and NECA significantly relaxed the minimum force and decreased the contraction frequency without any effect on the maximum force. The order of potency was: NECA greater than L-PIA greater than adenosine. Nifedipine, verapamil and diltiazem significantly relaxed the maximum force and increased the contraction frequency without a significant relaxing effect on minimum force. It is, therefore, likely that adenosine (and its analogs) and Ca2+ entry blockers have different mechanisms for the relaxation of coronary smooth muscle and that adenosine probably relaxes the vessels through A2 receptor.lld:pubmed
pubmed-article:3409957pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3409957pubmed:languageenglld:pubmed
pubmed-article:3409957pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3409957pubmed:citationSubsetIMlld:pubmed
pubmed-article:3409957pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3409957pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3409957pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3409957pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3409957pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3409957pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3409957pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3409957pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3409957pubmed:statusMEDLINElld:pubmed
pubmed-article:3409957pubmed:monthMaylld:pubmed
pubmed-article:3409957pubmed:issn0014-2999lld:pubmed
pubmed-article:3409957pubmed:authorpubmed-author:NakazawaMMlld:pubmed
pubmed-article:3409957pubmed:authorpubmed-author:MustafaS JSJlld:pubmed
pubmed-article:3409957pubmed:issnTypePrintlld:pubmed
pubmed-article:3409957pubmed:day10lld:pubmed
pubmed-article:3409957pubmed:volume149lld:pubmed
pubmed-article:3409957pubmed:ownerNLMlld:pubmed
pubmed-article:3409957pubmed:authorsCompleteYlld:pubmed
pubmed-article:3409957pubmed:pagination345-9lld:pubmed
pubmed-article:3409957pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:3409957pubmed:meshHeadingpubmed-meshheading:3409957-...lld:pubmed
pubmed-article:3409957pubmed:meshHeadingpubmed-meshheading:3409957-...lld:pubmed
pubmed-article:3409957pubmed:meshHeadingpubmed-meshheading:3409957-...lld:pubmed
pubmed-article:3409957pubmed:meshHeadingpubmed-meshheading:3409957-...lld:pubmed
pubmed-article:3409957pubmed:meshHeadingpubmed-meshheading:3409957-...lld:pubmed
pubmed-article:3409957pubmed:meshHeadingpubmed-meshheading:3409957-...lld:pubmed
pubmed-article:3409957pubmed:meshHeadingpubmed-meshheading:3409957-...lld:pubmed
pubmed-article:3409957pubmed:meshHeadingpubmed-meshheading:3409957-...lld:pubmed
pubmed-article:3409957pubmed:meshHeadingpubmed-meshheading:3409957-...lld:pubmed
pubmed-article:3409957pubmed:meshHeadingpubmed-meshheading:3409957-...lld:pubmed
pubmed-article:3409957pubmed:meshHeadingpubmed-meshheading:3409957-...lld:pubmed
pubmed-article:3409957pubmed:year1988lld:pubmed
pubmed-article:3409957pubmed:articleTitleEffects of adenosine and calcium entry blockers on 3,4-diaminopyridine-induced rhythmic contractions in dog coronary artery.lld:pubmed
pubmed-article:3409957pubmed:affiliationDepartment of Pharmacology, School of Medicine, East Carolina University, Greenville, NC 27834.lld:pubmed
pubmed-article:3409957pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3409957pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:3409957pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3409957lld:pubmed